Ono Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3197600004
JPY
2,178.50
14 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,27,536.00
1,12,309.00
1,34,223.00
1,22,664.00
1,17,675.00
1,12,769.00
1,31,191.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,27,536.00
1,12,309.00
1,34,223.00
1,22,664.00
1,17,675.00
1,12,769.00
1,31,191.00
Raw Material Cost
37,013.00
45,237.00
45,836.00
27,206.00
29,671.00
31,664.00
30,697.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
773.00
2,459.00
0.00
3,447.00
75.00
0.00
1,106.00
Selling and Distribution Expenses
31,086.00
31,932.00
35,315.00
30,538.00
27,886.00
26,975.00
25,691.00
Other Expenses
3,547.90
4,033.50
3,826.90
3,649.90
2,878.20
3,568.10
2,602.60
Total Expenditure (Excl Depreciation)
1,04,351.00
1,19,963.00
1,19,420.00
97,690.00
86,414.00
94,320.00
83,520.00
Operating Profit (PBDIT) excl Other Income
23185
-7654
14803
24974
31261
18449
47671
Other Income
238.00
-2,717.00
2,598.00
-203.00
2,123.00
-2,003.00
1,432.00
Operating Profit (PBDIT)
32,661.00
-1,643.00
26,571.00
29,388.00
37,763.00
21,157.00
53,446.00
Interest
773.00
2,459.00
0.00
3,447.00
75.00
0.00
1,106.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
90,523.00
67,072.00
88,387.00
95,458.00
88,004.00
81,105.00
1,00,494.00
Depreciation
9,238.00
8,728.00
9,170.00
4,617.00
4,379.00
4,711.00
4,343.00
Profit Before Tax
22,650.00
-12,831.00
17,399.00
21,325.00
33,310.00
16,445.00
47,996.00
Tax
5,019.00
-6,341.00
2,514.00
4,516.00
8,474.00
-988.00
11,906.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17,589.00
-6,545.00
14,939.00
16,860.00
24,793.00
17,434.00
36,053.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17,589.00
-6,545.00
14,939.00
16,860.00
24,793.00
17,434.00
36,053.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
42.00
178.00
-53.00
-48.00
42.00
-4.00
37.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17,631.00
-6,367.00
14,886.00
16,812.00
24,835.00
17,430.00
36,090.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,72,638.00
7,82,451.00
8,15,918.00
7,82,463.00
8,10,731.00
7,92,961.00
7,84,657.00
Earnings per share (EPS)
37.58
-13.93
31.81
35.86
52.75
36.91
75.77
Diluted Earnings per share
37.58
-13.93
31.81
35.86
52.75
36.91
75.77
Operating Profit Margin (Excl OI)
18.18%
-6.82%
11.03%
20.36%
26.57%
16.36%
36.34%
Gross Profit Margin
25.0%
-3.65%
19.79%
21.15%
32.03%
18.76%
39.9%
PAT Margin
13.79%
-5.83%
11.13%
13.74%
21.07%
15.46%
27.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 8.38% vs -1.95% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -29.01% vs -21.95% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -9.03% vs -23.05% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 930.67% vs -68.88% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Ono Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,27,536.00
99,781.00
27,755.00
27.82%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,27,536.00
99,781.00
27,755.00
27.82%
Raw Material Cost
37,013.00
12,802.00
24,211.00
189.12%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
773.00
2,331.00
-1,558.00
-66.84%
Selling and Distribution Expenses
31,086.00
25,820.00
5,266.00
20.40%
Other Expenses
3,547.90
2,255.70
1,292.20
57.29%
Total Expenditure (Excl Depreciation)
1,04,351.00
63,510.00
40,841.00
64.31%
Operating Profit (PBDIT) excl Other Income
23,185.00
36,271.00
-13,086.00
-36.08%
Other Income
238.00
12,389.00
-12,151.00
-98.08%
Operating Profit (PBDIT)
32,661.00
53,673.00
-21,012.00
-39.15%
Interest
773.00
2,331.00
-1,558.00
-66.84%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
90,523.00
86,979.00
3,544.00
4.07%
Depreciation
9,238.00
5,013.00
4,225.00
84.28%
Profit Before Tax
22,650.00
46,328.00
-23,678.00
-51.11%
Tax
5,019.00
6,980.00
-1,961.00
-28.09%
Provisions and contingencies
0
0
0.00
Profit After Tax
17,589.00
39,355.00
-21,766.00
-55.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17,589.00
39,355.00
-21,766.00
-55.31%
Share in Profit of Associates
0
0
0.00
Minority Interest
42.00
-7.00
49.00
700.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17,631.00
39,348.00
-21,717.00
-55.19%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,72,638.00
13,78,257.00
-6,05,619.00
-43.94%
Earnings per share (EPS)
37.58
46.25
-8.67
-18.75%
Diluted Earnings per share
37.58
46.25
-8.67
-18.75%
Operating Profit Margin (Excl OI)
18.18%
36.35%
0.00
-18.17%
Gross Profit Margin
25.00%
51.45%
0.00
-26.45%
PAT Margin
13.79%
39.44%
0.00
-25.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 12,753.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 13.56% vs -16.33% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 8.38% vs -1.95% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,763.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 376.91% vs -142.77% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -29.01% vs -21.95% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,242.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 2,918.90% vs -95.52% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -9.03% vs -23.05% in Jun 2024

Quarterly - Interest
Interest 77.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -68.56% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 930.67% vs -68.88% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.18%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024